Commentary: Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2020-01, Vol.9, p.1490-1490
Main Authors: Ripoll, Giselle V, Pifano, Marina, Garona, Juan, Alonso, Daniel F
Format: Article
Language:English
Subjects:
desmopressin
drug repurposing
hormone-resistant cancer
Oncology
relcovaptan
vasopressin
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2019.01490